Hypolipidemic Activity of New Phenoxyacetic Derivatives Related to α-Asarone with Minimal Pharmacophore Features

Drug Development Research

Volumn 60, Issue 3, 2003, Pages 186-195

  Del Carmen Cruz, María ^a   Salazar, María ^a   Garciafigueroa, Yésica ^a   Hernández, Dolores ^a   Díaz, Francisco ^a   Chamorro, Germán ^a   Tamariz, Joaquín ^a  

^a INSTITUTO POLITÉCNICO NACIONAL   (Mexico)

Author keywords

asarone; Hypocholesterolemia; Minimal pharmacophores; Phenoxyacetic scaffold

Indexed keywords

2 METHOXY 4 METHYLPHENOXYACETIC ACID; 2 METHOXY 5 METHYLPHENOXYACETIC ACID; 2 METHYLPHENOXYACETIC ACID; 3 METHYLPHENOXYACETIC ACID; 4 METHYLPHENOXYACETIC ACID; ALPHA ASARONE; ETHYL 2 METHOXY 4 METHYLPHENOXYACETATE; ETHYL 2 METHOXY 5 METHYLPHENOXYACETATE; ETHYL 2 METHYLPHENOXYACETATE; ETHYL 3 METHYLPHENOXYACETATE; ETHYL 4 METHYLPHENOXYACETATE; METHYL 2 METHOXY 4 METHYLPHENOXYACETATE; METHYL 2 METHOXY 5 METHYLPHENOXYACETATE; METHYL 2 METHYLPHENOXYACETATE; METHYL 3 METHYLPHENOXYACETATE; METHYL 4 METHYLPHENOXYACETATE; PHENOXYACETIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DOSE RESPONSE; DRUG ACTIVITY; DRUG POTENCY; DRUG STRUCTURE; DRUG SYNTHESIS; HYPOLIPEMIA; ISOMERISM; MALE; MOUSE; NONHUMAN; PHARMACOPHORE; STRUCTURE ACTIVITY RELATION; TRIACYLGLYCEROL BLOOD LEVEL;

EID: 0242299718     PISSN: 02724391     EISSN: None     Source Type: Journal    
DOI: 10.1002/ddr.10281     Document Type: Article

References (17)

1. Chamorro G, Salazar M, Salazar S, Mendoza T. 1993. Farmacología y toxicología de Guatteria gaumeri. Rev Inv Clin 45:597-604.
2. Chamorro G, Garduño L, Sánchez A, Labarrios F, Salazar M, Martínez E, Díaz F, Tamariz J. 1998. Hypolipidaemic activity of dimethoxy unconjugated propenyl side-chain analogs of α-asarone. Drug Dev Res 43:105-108.
3. Cruz A, Garduño L, Salazar M, Martínez E, Díaz F, Chamorro G, Tamariz J. 2001a. High hypolipidemic activity of saturated side-chain α-asarone analogs. Med Chem Res 10:587-595.
4. Cruz A, Garduño L, Salazar M, Martínez E, Jiménez-Vázquez HA, Díaz F, Chamorro G, Tamariz J. 2001b. Synthesis and hypolipidemic activity of modified side-chain α-asarone homologues. Arzneimittel-Forsch 51:535-544.
5. Díaz F, Muñoz H, Labarrios F, Chamorro G, Salazar M, Morelos ME, Tamariz J. 1993. Synthesis and hypolipidemic activity of some α-asarone analogues. Med Chem Res 3:101-109.
6. Garduño L, Salazar M, Salazar S, Morelos ME, Labarrios F, Tamariz J, Chamorro GA. 1997. Hypolipidaemic activity of α-asarone in mice. J Ethnopharmacol 55:161-163.
7. Hall IH, Chapman JM, Voorstad PJ, Cocolas GH. 1984 Hypolipidemic activity of 3-N-(1′, 8′-naphtalimido) propionic acid in rodents. J Pharm Sci 73:956-960.
8. Higginbotham L, Stephen H. 1920. Studies in the coumaranone series. Part I. The preparation of 4-, 5-, and 6-methylcoumaran-2-ones, and some derivatives of o-, m-, and p-tolyloxyacetic acids. J Chem Soc 117:1534-1542.
9. Hirota M, Hirano G. 1972. Intramolecular hydrogen bonding in α-keto and α-alkoxy carboxylic acids. VIII. o-Methoxy-substituted phenoxyacetic and phenylthioacetic acids. Bull Chem Soc Jpn 45: 1448-1452.
10. Kannel WB, Sytkowsky, PA. 1987. Atherosclerosis risk factors. Pharmacol Therapeut 32:207-235.
11. Labarrios F, Garduño L, Vidal MR, García R, Salazar M, Martínez E, Díaz F, Chamorro G, Tamariz J. 1999. Synthesis and hypolipidemic evaluation of a series of α-asarone analogues related to clofibrate in mice. J Pharm Pharmacol 51:1-7.
12. Momin AA, Nair MG. 2002. Pest-managing efficacy of trans-asarone isolated from Daucus carota L. Seeds. J Agric Food Chem 50:4475-4478.
13. Poplawski J, Lozowicka B, Dubis AT, Lachowska B, Witkowski S, Siluk D, Petrusewicz J, Kaliszan R, Cybulski J, Strzalkowska M, Chilmonczyk ZJ. 2000. Synthesis and hypolipidemic and antiplatelet activities of α-asarone isomers in humans (in vitro), mice (in vivo), and rats (in vivo). Med Chem 43:3671-3676.
14. Schwarz R, Hering H. 1963. Creosol. In: Rabjohn N, editor. Organic syntheses. New York: John Wiley&Sons. p 203-205.
15. Tallarida RJ, Murray RB. 1987. Manual of pharmacological calculations: New York: Springer Verlag. 150 p.
16. Vickery EH, Pahler LF, Eisenbraun EJ. 1979. Selective O-demethylation of catechol ethers. Comparison of boron tribromide and iodotrimethylsilane. J Org Chem 44:4444-4446.
17. Vogel RA, Conneti MC, Gellman J. 1998. Cholesterol, cholesterol lowering, and endothelial function. Prog Cardiovasc Dis 41:117-136.